Search

everythinglearnresearchcommunity

for

Search:↓

A new method was created to test the effectiveness of Dihydrotestosterone (DHT) inhibitors, like finasteride and dutasteride, in human and fish cells. The results showed fish cells are more sensitive to these treatments, and dutasteride works better than finasteride in all tested cells.

A new, efficient method creates sulfinimidate esters from sulfenamides and alcohols without metals.

The new adhesive seals wounds quickly, works well in wet conditions, and helps with healing.

Unripe fruits of three banana species have many health-boosting compounds useful for medicine.

The study concluded that both estrogen and androgen receptors, which decrease with age, are linked to skin aging and may be hormonally regulated.

Prolactin affects hair growth cycles and can cause early hair follicle regression.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Menopausal acne is treated with medications and lifestyle changes, but careful choice is needed due to side effects.

The document concludes that HAIR-AN syndrome should be considered when a patient shows severe hyperandrogenism and insulin resistance after excluding tumors.

DHT may increase the risk of heart disease and death in elderly men.

Some newly made compounds can block an enzyme linked to hair loss and prostate growth, with one in particular being very selective.

The document reviews 20 U.S. patents from July and August 2004 about new drug forms, cancer treatments, aroma chemicals, statin drugs, and various chemical production methods.

The enzyme that changes testosterone to a stronger form is mostly found in the part of the hair follicle called the dermal papilla.

The enzymes 5α-reductase and 3α/β-hydroxysteroid oxidoreductase help create brain-active substances from progesterone and testosterone, which could be used for treatment, but more research is needed to ensure their safety and effectiveness.

Higher levels of unbound testosterone are linked to increased insulin resistance, especially in women with polycystic ovary syndrome.

Male pattern baldness may be caused by factors like poor blood circulation, scalp tension, stress, and hormonal imbalances, but the exact causes are still unclear.

Hair growth slows and shedding increases after childbirth, but most women don't experience excessive hair loss.

Flutamide, an antiandrogen, has minimal impact on female rat endocrine systems and does not significantly change their reproductive cycles.

Certain genetic variations in the AR and ERβ genes can affect androgen levels in women.

Finasteride, CPA, and flutamide are all equally effective in reducing excessive hair growth in women.

Excessive hair growth in women often has no known cause and is not linked to race or other hormonal symptoms.

Hormones and genetics play key roles in male and female baldness, which can affect mental health and may be linked to other health issues.

The document concludes that combination therapy is most effective for treating excessive hair growth in women with idiopathic hirsutism, and more research is needed to understand the condition.

AKR1C3 could be a treatment target for metabolic issues in PCOS.

Creating stronger blockers for skin enzymes might lead to better treatment for conditions like acne and excessive hair growth.

5α-reductase inhibitors can interfere with doping tests by masking banned substances.

3α, 17β-androstanediol-glucuronide is not a useful marker for androgen excess but may help monitor certain treatments.

Early diagnosis and individualized treatment improve outcomes for Congenital Adrenal Hyperplasia.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.